Navidea Biopharmaceuticals, Inc.(NYSE Amex Equities : NAVB)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.04% | 53.95 | 0.9% | $1407.48m | |
| JNJ | Johnson & Johnson | -0.19% | 179.20 | 0.7% | $1293.99m | |
| BMY | Bristol-Myers Squibb Co. | 0.27% | 77.80 | 1.0% | $1215.44m | |
| MRK | Merck & Co., Inc. | -0.02% | 92.30 | 0.7% | $1166.77m | |
| ABBV | AbbVie, Inc. | -0.26% | 150.17 | 1.9% | $1097.45m | |
| LLY | Eli Lilly & Co. | -0.15% | 313.00 | 1.1% | $965.80m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.14% | 142.98 | 0.0% | $491.89m | |
| AZN | AstraZeneca Plc | -0.05% | 66.67 | 1.0% | $491.28m | |
| NVS | Novartis AG | 0.07% | 91.32 | 0.2% | $260.02m | |
| GSK | GlaxoSmithKline Plc | 0.01% | 44.42 | 0.2% | $257.59m | |
| VERU | Veru, Inc. | 0.47% | 12.70 | 0.0% | $254.91m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 90.59 | 5.4% | $196.03m | |
| SGEN | Seagen Inc. | 0.46% | 139.10 | 5.7% | $186.52m | |
| NVO | Novo Nordisk A/S | -0.64% | 105.94 | 0.1% | $181.73m | |
| VTRS | Viatris, Inc. | 0.58% | 12.08 | 0.0% | $166.23m |
Company Profile
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.